Analysts Buzz

DISCO Pharmaceuticals: Revolutionizing Cancer Treatment through Surfaceome Mapping

DISCO Pharmaceuticals, a pioneering biotech company, has officially emerged from stealth mode with a breakthrough technology aimed at unlocking the surfaceome of cancer cells. This revolutionary approach facilitates the identification of new targets and the development of first-in-class drugs. Headquartered in Cologne, Germany, and Schlieren, Switzerland, DISCO has successfully secured seed financing of EUR 20…

Read More

Accelalpha EMEA: A Transformative Merger for Oracle Cloud Solutions

In a strategic move since August 2022, Frontera Consulting and Accelalpha completed a global merger, unifying their strengths in Oracle Cloud consulting and managed services. This collaboration resulted in an exceptional 100% revenue growth over the year, culminating in Frontera Consulting UK gracefully retiring its name on January 1st, 2024. The newly formed entity, Accelalpha…

Read More